Larvol Delta - cAMeLot2-A-Study-of-Bleximenib-Venetoclax-and-Azacitidine-For-Treatment-of-Participants-With-Newly-Diagnosed-Acute-Myeloid-Leukemia-AML

bleximenib (JNJ-6617) - J&J

Venclexta (venetoclax) - Roche, AbbVie

azacitidine - Generic mfg.

http://clinicaltrials.gov/ct2/show/NCT06852222

Jul 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next